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Introduction of a novel magnetic resonance
imaging-based scoring system for assessing disease
activity in children with juvenile dermatomyositis
Mandela Thyoka1, Oba Adekunley, Clarissa Pilkington2, Stephen Walters3,
Owen J. Arthurs4, Paul Humphries4,5, Karl Johnson6, Jeannette Kraft7,
Caren Landes8, Thara Persaud9, Raj Sinha10 and Amaka C. Offiah11
Abstract
Objectives. We aimed to develop and assess the reliability of a novel MRI-based scoring system for reporting the
severity of MRI findings in children with suspected JDM.
Methods. Nine consultant paediatric radiologists independently assessed and scored 40 axial and 30 coronal thigh MR
images of children with suspected JDM on two occasions using the juvenile dermatomyositis magnetic resonance
Imaging Score (JIS). JIS was calculated for both reads for each plane and each limb, with possible scores ranging
from 0 (normal) to 100 (severe). Inter- and intraobserver agreement was calculated using the intraclass correlation
coefficient (ICC) and two- and one-way random effects models, respectively. Bland-Altman plots of the difference in
JIS against the average JIS were also produced for each rater.
Results. Overall, the interobserver reliability and agreement was good—for axial images, JIS ranged from 46.8 to 61.0 [ICC =
0.88 (95% CI: 0.82, 0.92)] for the left limb and 47.961.4 [ICC = 0.87 (95% CI: 0.81, 0.92)] for the right limb. For coronal images,
JIS ranged from 56.7 to 65.1 [ICC = 0.90 (95%CI: 0.85, 0.95)] for the left limb and 55.7 to 66.8 [ICC = 0.90 (95%CI: 0.84, 0.94)] for
the right limb. The intraobserver reliability and agreement was good, with ICC ranging from 0.90 to 0.94.
Conclusion. JIS is a semi-objective scoring system with potential to serve as a reliable biomarker of disease severity
and response to therapeutic interventions in children with JDM.
Key words: juvenile dermatomyositis, magnetic resonance imaging (MRI), scoring system, children, creatine
kinase, electromyogram
Rheumatology key messages
. We have developed a consensus MRI protocol for JDM.
. We have developed a reliable MRI-based semi-quantitative scoring tool for JDM (JDM MRI Score).
. JDM MRI Score provides a standardized tool for clinical and research use.
Introduction
JDM is a rare autoimmune disease in children (<16 years
of age). It is a systemic vasculopathy, characterized by
proximal muscle weakness, raised muscle enzymes and
characteristic skin rash (Gottron’s papules of extensor
surfaces and a heliotrope rash of the eyelids). JDM is
the most common inflammatory myopathy in childhood
[1], with an estimated annual incidence of 23/million chil-
dren. The median age of onset is 7 years. Girls are more
commonly affected than boys [2, 3].
In 1975 Bohan and Peter [4, 5] published criteria for the
diagnosis of JDM. Definite diagnosis of JDM is made in
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the presence of the characteristic skin rash plus three or
of four of the following: systemic proximal muscle weak-
ness; elevated muscle enzymes; characteristic pathology
on muscle biopsy; and a myopathic picture on EMG. The
combination of the rash plus three or four criteria confirms
the diagnosis; the rash plus two criteria indicates probable
disease, while the rash plus one criterion indicates pos-
sible disease. To date this remains the only validated
diagnostic system, despite the fact that it predates wide-
spread clinical use of MRI and therefore does not include
MRI as one of the diagnostic criteria.
MRI is an imaging modality that does not expose the
child to ionizing radiation. The study by Kaufman et al. [6]
was one of the earliest to assess the role of MRI for JDM
(and polymyositis). In the context of JDM, i.v. contrast
administration is probably not indicated, and because af-
fected children are usually of a co-operative age, sedation
is seldom required. As such, MRI in suspected JDM is
relatively non-invasive (less so than muscle enzymes,
EMG and muscle biopsy for example). MRI has been
used both for the diagnosis of JDM (including selection
of sites for muscle biopsy) and to monitor treatment
[1, 79]. Diagnostic sensitivity of MRI is 76% compared
with 64% for elevated serum creatine kinase [4].
Furthermore, increased MR signal intensity secondary to
inflammation within muscle correlates better with disease
activity than does elevated creatine kinase [7, 10, 11].
Finally, MRI was considered an important diagnostic cri-
terion and (together with muscle biopsy) rated the most
useful clinically relevant investigative criterion for JDM by
78 respondents of a survey of members of the Network for
JDM and the Paediatric Rheumatology International Trials
organization [12].
Given that JDM is associated with a proximal myop-
athy, it is generally accepted that images of the gluteal
and thigh muscles are sufficient for both diagnosis and
follow-up. In the UK the practice is varied with MRI
images obtained in the coronal plane alone, in the axial
plane alone or (rarely) in both planes depending on local
preference. However, some European centres are per-
forming whole-body MRI in suspected JDM [13]. To
date, no objective assessment has been made as to
which plane or body site is most reliable for assessing
disease activity in JDM. Similarly, there is variation be-
tween centres regarding the precise sequences to per-
form. Various combinations of techniques—T1-weighted
(muscle atrophy; chronic disease) and T2-weighted/fat
suppression (soft tissue oedema; active disease)—pro-
vide useful information [7, 10, 11, 14]. Short tau inversion
recovery (STIR) sequences improve the visualization of
inflammatory change in the skin, subcutaneous tissues
and fascia, which are often undetected by standard T1
and T2 sequences [14].
Muscle T2-weighted relaxation times differ significantly
in children with active JDM compared with both children
with inactive JDM and healthy children, and T2-weighted
relaxation times could therefore serve as a quantitative
measure of muscle inflammation [7, 8]. However, meas-
urement of T2-weighted relaxation times requires
computer software that is not widely available and oper-
ator-dependent selection of regions of interest (which is
difficult in the presence of muscle wasting), and does not
assess other parameters such as subcutaneous inflam-
mation, perifascicular oedema, calcinosis and muscle at-
rophy. Uniformity in performing and reporting MR images
is necessary from a clinical point of view, and if improve-
ments are to be made in health outcomes for affected
children, then reliable imaging and reporting are also im-
portant in the research setting; MRI has the potential to be
used as a relatively rapid, non-invasive and reliable end-
point for clinical trials. In summary, despite widespread
utility, there is currently no uniformity in the MRI planes
and sequences or in the reporting of MRI scans for sus-
pected or confirmed JDM.
We have previously developed and published an MRI-
based scoring system for JDM [15]. Although intraobser-
ver reliability was good, interobserver reliability was only
fair. Considering the latter limitation, the purpose of this
current study was to refine the scoring system including
the involvement of a larger panel of observers, in order to
improve reliability prior to a prospective validation study.
As a secondary goal, we sought to determine which MRI
sequences and planes should routinely be performed
when JDM is suspected so as to provide uniformity be-
tween practitioners.
Methods
Panel of assessors
Nine UK-based paediatric radiologists with an interest in
musculoskeletal imaging constituted the multicentre
reader panel. The panel had two roles: collective modifi-
cation of the scoring system and independent assignment
of scores to pre-selected, anonymized MRI scans of
thighs for suspected JDM.
Development of the scoring system
The accuracy of the previously proposed scoring system
was acceptable for the single reader but showed high
variability between two different individuals [15]. In order
to address this issue, nine paediatric radiologists and two
paediatric rheumatologists (Liza McCann and C.P.) con-
vened in January 2014 for a preliminary roundtable meet-
ing (UK JDM Imaging Group, chaired by A.C.O.). During
this meeting, discussions were held regarding developing
a protocol for the MRI planes and sequences in addition
to optimizing the scoring system. The panel discussed the
previous MRI scoring system [15], identifying its limita-
tions. It was felt that the interobserver variability of the
previous system was largely due to the relative subjectiv-
ity of defining degree of inflammation for whole muscle
groups. Therefore, rather than modifying the system, the
group developed and familiarized themselves with a novel
MRI scoring system—JDM Image Score (JIS), using a set
of MR images from 20 patients. These images, constitut-
ing the familiarization set, did not feature further in the
project.
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Selection of study MR images
The MRI protocols for suspected JDM at the institutions of
panel members at the time of the study are summarized in
the supplementary Table S1, available at Rheumatology
online. MRI studies were selected and anonymized by
each panel member before being sent to O.A. to collate,
with a total of 50 axial and 32 coronal studies received. Of
these, 40 axial and 30 coronal studies were selected to
cover the spectrum of disease severity. The image selection
and mailing procedure was developed to reduce image
recall by observers and any effects of a learning curve on
assignment of JIS. Panel members read the digital imaging
and communications in medicine images from the compact
discs on high-resolution diagnostic monitors in identical
National Health Service settings to those used for interpret-
ation of images during usual clinical practice. Panel mem-
bers had full access to image manipulation (magnification,
brightness, etc.), used at the observers’ discretion.
JIS
The JIS was developed based on characteristic features
on MRI of affected limbs. JIS ranges from 0 (normal) to
100 (severe), based on the severity, extent and volume of
muscle inflammation and the presence of muscle and
perifascicular oedema (see JIS, Table 1). Severity of in-
flammation was assessed on the single most severely af-
fected slice on the plane being reported according to a
categorical scale (0 = none, 2 =mild, 4 =moderate, 6 = se-
vere). The extent of muscle inflammation was assessed by
an overall estimation of the number of consecutive slices
involved in the superoinferior (axial studies) or anteropos-
terior (coronal studies) direction. Similarly, the volume of
muscle inflammation was assessed by an overall estimation
of the relative volume of affected muscle. The presence of
perifascicular oedema was weighted with a relatively high
score, given the panel’s opinion that children with perifas-
cicular oedema have more severe disease and are more
likely to develop calcinosis. Additional assessment,
though not forming part of JIS, was made of the presence
of muscle atrophy and calcification. Using the thigh of each
limb, all four muscle groups (adductors, gluteals, ham-
strings and quadriceps) were independently assessed and
scored for inflammation. Additionally, the presence of peri-
fascicular oedema was scored (0=absent, 14=present).
The total scores were calculated to give the JIS. Fig. 1
shows example images that were scored as part of this
study.
Independent assignment of JDM image scores
Panel members independently scored all image sets on a
pre-designed online score sheet according to the newly
developed JIS (Table 1). For each score, the level of ob-
server confidence in assigning that score (5-point Likert
scale) was recorded.
Statistical analysis
All statistical analyses were made using International
Business Machines Corporation (IBM) Statistical
Package for the Social Science (SPSS) Statistics for
Windows, Version 24.0 (IBM Corp., Armonk, NY, USA).
The primary outcome was defined as the reliability (inter-
and intraobserver) of JIS. The secondary outcome was a
comparison of the reliability of JIS for coronal and axial
planes. For the MRI-based scoring system to be clinically
useful, we decided a priori that a minimum acceptable
level of reliability should be an intraclass correlation coef-
ficient (ICC) of 0.70 [16, 17].
Interobserver reliability
For each individual radiologist, JIS were graphically dis-
played and their overall mean score calculated.
Agreement between the observers (interobserver reliabil-
ity) using the JIS scoring system was assessed by calcu-
lating the ICC; a value of 1.00 corresponding to perfect
agreement. The ICC and its associated CI was estimated
in SPSS using a two-way random effects model and the
absolute agreement method.
Intraobserver reliability
For each individual radiologist, a Bland-Altman plot of the
mean score of the two reads against the difference
TABLE 1 JDM MRI score
Muscle group
Muscle inflammation Oedema
TotalSeverity Extent Volume Soft tissue Perifascicular
Adductors
Gluteals
Hamstrings
Quadriceps
Any locationa
Total
For each plane (axial and coronal) and each limb (left and right) independently score: muscle inflammation: 0=none, 2=mild,
4=moderate, 6= severe; soft tissue oedema: absent=0, present =14; perifascicular oedema: absent=0, present=14. Minimum
score=0 (normal); maximum score=100 (severe). Additionally, please note presence of (i) muscle atrophy and (ii) calcification.
aApplies only to oedema. The involved muscle group(s) must be specified for muscle inflammation.
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FIG. 2 Scatter plot matrix graph of JIS for left limb, axial plane
JIS: Juvenile dermatomyositis magnetic resonance Imaging Score.
FIG. 1 MRI images of a sample case used to develop JIS
(A) Axial image showing inflammation of all muscle groups and perifascicular oedema. (B) Coronal image of another
patient, showing inflammation of the proximal adductor muscles only. JIS: Juvenile dermatomyositis magnetic resonance
Imaging Score.
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between the two reads was produced and complimented
by the calculation of the 95% CI for the mean difference.
Agreement within the observers (intraobserver reliability)
using the JIS scoring system was assessed by calculating
the ICC; a value of 1.00 corresponding to perfect agree-
ment between the observers for their first and second
readings. The ICC and its associated CI was estimated
in SPSS using a one-way random effects model and the
absolute agreement method. Bland-Altman plots of the
difference in JIS (first to second reading) against the aver-
age JIS (first + second reading) were also produced for
each rater and the paired difference and its associated
95% CI calculated from a paired t-test.
Ethics approval
Formal Research and Ethics Committee approval was not
required for this study, which involved retrospective
review of anonymized images. The central institution
Sheffield Children’s Hospital NHS Trust approved the
protocol, confirming that Research and Ethics
Committee approval was not required, and provided in-
demnity (R&D: SCH/13/057).
Results
Nine of the 10 raters from eight UK National Health
Service Trusts (supplementary Table S1, available at
Rheumatology online) completed the full task, using JIS
to score axial and coronal images, left and right sides, on
two occasions. The raters were consultant paediatric radi-
ologists with a mean of 9.6 (range 418) years’ experience
between them. All but one of the eight centres used both
axial and coronal planes in their MRI protocol (one centre
used the axial plane only) and the sequence common to
all centres was the STIR (supplementary Table S1, avail-
able at Rheumatology online). Fig. 2 shows an example
scatterplot matrix graph of individual scores (JIS) of the
nine raters scoring one limb (left) in one plane (axial) only.
Interobserver reliability
Overall, interobserver reliability and agreement between
the nine raters was good (Fig. 3). For the 40 axial
images, the mean JIS for the left limb, across the nine
raters ranged from 46.8 to 61.0 and the ICC was 0.88
(95% CI: 0.82, 0.92), and for the right limb the mean JIS,
across the nine raters, ranged from 47.9 to 61.4 and the
ICC was 0.87 (95% CI: 0.81, 0.92).
For the 30 coronal images the mean JIS for the left limb,
across the nine raters, ranged from 56.7 to 65.1 and the
ICC was 0.90 (95% CI: 0.85 to 0.95), and for the right limb
the mean JIS, across the nine raters ranged from 55.7 to
66.8 with an ICC of 0.90 (95% CI: 0.84 to 0.94). The
intraobserver reliability and agreement for JIS was also
good, with the ICC values between the first and second
reads ranging from 0.90 to 0.94 (Table 2).
Discussion
Our study shows that JIS has good intra- and interobser-
ver agreement among paediatric radiologists when used
to assess the degree of muscle inflammation in suspected
cases of JDM and that the scores for disease severity are
the same in either axial or coronal planes. The level of
reliability of JIS is well above the minimum level of clinical
usefulness and applicability (0.70) [16, 17]. Similarly, we
have shown JIS to be independent of the plane of ima-
ging, with similar observer reliability whether reporting
from axial or coronal images. The previous scoring
system [14] assessed extent of muscle inflammation con-
sidering the entire muscle group under interrogation. This
is likely to have led to the fair interobserver reliability. In
contrast, JIS considers severity, extent and volume of
muscle inflammation, providing the observer with nar-
rower parameters by which to score the scans and result-
ing in a higher interobserver reliability. These results imply
that JIS can be used both as a reliable and semi-objective
tool for the diagnosis and monitoring of JDM in clinical
practice and as a reliable biomarker for disease severity
in research trials.
Although there have been a few attempts to develop
diagnostic criteria/classification systems for both adult
and juvenile idiopathic inflammatory myopathies [1821],
as far as we are aware, to date the only validated diagnos-
tic system in use specifically for JDM does not include MRI
findings [4, 5], despite the fact that MRI plays a fundamen-
tal role in the clinical management of JDM, both as a diag-
nostic tool and to monitor response to treatment [22].
The major limitation to the use of MRI is the lack of
uniformity in both the reporting/interpretation of MRI find-
ings in the clinical setting and in the planes and se-
quences performed; imaging protocols are based on
local preferences with some centres only obtaining
images in a single orthogonal plane (coronal or axial)
while others use both planes. This lack of uniformity
may partially explain why MRI (despite widespread
FIG. 3 ICC (with 95% CI) for axial and coronal planes
(ICC = 0.01.0)
ICC: intraclass correlation coefficient; JIS: Juvenile
dermatomyositis magnetic resonance Imaging Score.
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availability, lack of invasiveness and relatively rapid re-
sults) is not a diagnostic criterion for JDM. Recently,
modifications to the current diagnostic criteria have
been proposed to include evidence of myopathy on MRI
[12, 23]; as such, JIS could prove invaluable in ensuring
comparable, uniform reporting and interpretation.
We assessed MR images of the gluteal and thigh mus-
cles for JIS as these sufficiently locate the proximal my-
opathy that is a clinical feature of JDM. Although no
objective assessment was made as to which plane is
the most useful in terms of correlation with clinical sever-
ity, our study has shown no significant difference in MRI
severity scores when using either the axial or coronal
planes. Various combinations of techniques—T1-
weighted (muscle atrophy; chronic disease) and T2-
weighted/fat suppression (soft tissue oedema; active
disease)—provide useful information. STIR sequences im-
prove the visualization of inflammatory change in the skin,
subcutaneous tissues and fascia, which are often un-
detected by standard sequences. There is nothing to be
gained by performing both a T2-weighted and an inver-
sion recovery sequence. Others have advocated the use
of whole-body MRI as it provides additional information to
clinical evaluation in estimation of total inflammatory
burden when compared with clinical assessment of dis-
ease activity by such measures as the Manual Muscle
Test and the Childhood Myositis Assessment Scale [13].
Although whole-body MRI may be a reliable tool in as-
sessing the full extent of the disease, we advocate the
use of MRI of proximal lower limb muscles as this is the
site of predilection of the inflammatory changes in JDM
and because localized MRI is now available in most pae-
diatric centres, whereas whole-body MRI is not. As far as
we know, no formal studies have been performed to
assess the role of contrast in the context of suspected
JDM; nevertheless, the panel agreed that i.v. gadolinium
was not needed, even though some of the centres had
until this study been routinely using it.
An MRI-based scoring system such as JIS offers sig-
nificant advantages in comparison with other diagnostic
investigations (muscle enzymes, EMG or muscle biopsy)
that are currently used in children with suspected JDM.
Firstly, MRI is a relatively non-invasive, non-ionizing inves-
tigation and neither contrast administration nor sedation is
usually required in the setting of suspected JDM. In
addition, MRI can be used to guide biopsies when JDM
is suspected [24]. The diagnostic sensitivity of MRI com-
pares favourably to that of elevated serum creatine kinase
and the increased signal intensity seen on MRI due to
muscle inflammation correlates better with disease activ-
ity than does elevated creatine kinase [10, 11, 25]. MRI
discriminates between affected and non-affected muscle
groups by visualizing oedema from acute inflammation
and the signal intensity is associated with disease activity
in the acute presentation of JDM. Finally, if local expertise
does not extend to reporting of the images, with current
advances in information and technology, their transfer
across centres allows ease of access to MRI images by
specialist radiologists. If the correct plane and sequences
are obtained locally, this will significantly speed up the
diagnostic pathway for the patient at the specialist referral
centre and allow prompt initiation of appropriate therapy
and improved patient outcomes.
There are several limitations of this study. Firstly, as we
did not have access to the clinical data to provide an
index of clinical disease assessment, we were not able
to show the difference in the clinical value of either the
axial or coronal sets of images. However, our study has
shown that there is agreement between these two orthog-
onal planes when scoring for radiological disease severity
markers and therefore images are required in only one
plane. Secondly, the study is limited by its retrospective
design; however, our chosen methodology is appropriate
for the purposes of developing a scoring system. Thirdly,
since it is known that the intensity of inflammation on MR
scans decreases significantly after treatment, but the his-
tologically detected inflammation does not change sub-
stantially [20], an MRI-based score may be beneficial at
the onset prior to commencement of treatment, but the
score may underestimate the burden of inflammation
once treatment has commenced. Fourthly, JIS is a semi-
objective scoring system, which means some observer
subjectivity cannot be avoided; however, we could further
have reduced subjectivity by providing guidelines for
defining muscle involvement, for example, volume (mild
425%, moderate = 2650% and severe 51% involve-
ment). The use of such criteria should be assessed in a
future prospective study. Furthermore, we gave perifasci-
cular oedema a weighted score because of its prognostic
importance as, according to our panel, children with
TABLE 2 Intraobserver reliability of the nine observers (testre-test) for coronal and axial images of left and right limbs
Mean JIS
Paired difference (95% CI) ICC (95% CI)Plane Limb N First reading Second reading
Coronal Left 54 58.3 59.4 1.1 (4.7, 2.4) 0.91 (0.85, 0.95)
Coronal Right 54 58.7 60.2 1.6 (5.3, 2.1) 0.90 (0.84, 0.94)
Axial Left 72 56.1 56.4 0.3 (3.2, 2.5) 0.93 (0.89, 0.96)
Axial Right 72 57.0 56.7 0.3 (2.3, 2.9) 0.94 (0.91, 0.96)
The nine raters each re-scored six different coronal images a second time, and re-scored eight different axial plane images a
second time. JIS: Juvenile dermatomyositis magnetic resonance Imaging Score.
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perifascicular oedema have more severe disease and are
more likely to develop calcinosis. The weighted score of
14 was chosen to allow JIS to reach a convenient max-
imum score of 100. This may overemphasize the signifi-
cance of perifascicular oedema but will do so equally in all
affected patients. Finally, JIS has not been clinically vali-
dated in a multicentre prospective study—this is our in-
tended next step and the prospective nature of such a
study will also allow longitudinal comparison of JIS and
other clinical and laboratory parameters of disease
progression.
In conclusion, JIS is a reliable semi-objective method of
conveying the degree of muscle inflammation in sus-
pected JDM and has good intra- and interobserver agree-
ment among paediatric radiologists in both axial and
coronal planes. We recommend routine axial STIR (or T2
weighted fat saturated) and T1 weighted sequences of the
thighs as the disease severity scores are the same in
either axial or coronal planes. JIS has potential to provide
clinicians and researchers with a reliable biomarker of dis-
ease severity and response to therapeutic interventions in
children with JDM and as such provide a uniform platform
for reporting clinical and research findings.
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